These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

293 related articles for article (PubMed ID: 25038431)

  • 1. Mesalamine did not prevent recurrent diverticulitis in phase 3 controlled trials.
    Raskin JB; Kamm MA; Jamal MM; Márquez J; Melzer E; Schoen RE; Szalóki T; Barrett K; Streck P
    Gastroenterology; 2014 Oct; 147(4):793-802. PubMed ID: 25038431
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A randomized controlled study of mesalamine after acute diverticulitis: results of the DIVA trial.
    Stollman N; Magowan S; Shanahan F; Quigley EM;
    J Clin Gastroenterol; 2013 Aug; 47(7):621-9. PubMed ID: 23426454
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Budesonide is more effective than mesalamine or placebo in short-term treatment of collagenous colitis.
    Miehlke S; Madisch A; Kupcinskas L; Petrauskas D; Böhm G; Marks HJ; Neumeyer M; Nathan T; Fernández-Bañares F; Greinwald R; Mohrbacher R; Vieth M; Bonderup OK;
    Gastroenterology; 2014 May; 146(5):1222-30.e1-2. PubMed ID: 24440672
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Preventing diverticulitis recurrence by selecting the right therapy for a complex disease.
    Tursi A; Danese S
    Gastroenterology; 2014 Oct; 147(4):733-6. PubMed ID: 25167986
    [No Abstract]   [Full Text] [Related]  

  • 5. Preventing diverticulitis: mesalamine may still be indicated in the decision.
    Floch MH
    Gastroenterology; 2015 Apr; 148(4):856. PubMed ID: 25726738
    [No Abstract]   [Full Text] [Related]  

  • 6. Effect of oral mesalamine on inflammatory response in acute uncomplicated diverticulitis.
    Nespoli L; Lo Bianco G; Uggeri F; Romano F; Nespoli A; Bernasconi DP; Gianotti L
    World J Gastroenterol; 2015 Jul; 21(27):8366-72. PubMed ID: 26217088
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Randomised clinical trial: mesalazine versus placebo in the prevention of diverticulitis recurrence.
    Kruis W; Kardalinos V; Eisenbach T; Lukas M; Vich T; Bunganic I; Pokrotnieks J; Derova J; Kondrackiene J; Safadi R; Tuculanu D; Tulassay Z; Banai J; Curtin A; Dorofeyev AE; Zakko SF; Ferreira N; Björck S; Diez Alonso MM; Mäkelä J; Talley NJ; Dilger K; Greinwald R; Mohrbacher R; Spiller R
    Aliment Pharmacol Ther; 2017 Aug; 46(3):282-291. PubMed ID: 28543263
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Reply: To PMID 25167986.
    Raskin JB; Kamm MA; Streck P
    Gastroenterology; 2015 Apr; 148(4):856-7. PubMed ID: 25726740
    [No Abstract]   [Full Text] [Related]  

  • 9. Mesalazine to treat symptomatic uncomplicated diverticular disease and to prevent acute diverticulitis occurrence. A systematic review with meta-analysis of randomized, placebo-controlled trials.
    Picchio M; Elisei W; Tursi A
    J Gastrointestin Liver Dis; 2018 Sep; 27(3):291-297. PubMed ID: 30240473
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Efficacy and safety of Fufangkushen colon-coated capsule in the treatment of ulcerative colitis compared with mesalazine: a double-blinded and randomized study.
    Gong Y; Zha Q; Li L; Liu Y; Yang B; Liu L; Lu A; Lin Y; Jiang M
    J Ethnopharmacol; 2012 Jun; 141(2):592-8. PubMed ID: 21911045
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mesalazine for People with Diverticular Disease: A Systematic Review of Randomized Controlled Trials.
    Iannone A; Ruospo M; Wong G; Barone M; Principi M; Di Leo A; Strippoli GFM
    Can J Gastroenterol Hepatol; 2018; 2018():5437135. PubMed ID: 30320044
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Diverticular disease as a chronic illness: evolving epidemiologic and clinical insights.
    Strate LL; Modi R; Cohen E; Spiegel BM
    Am J Gastroenterol; 2012 Oct; 107(10):1486-93. PubMed ID: 22777341
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Treatment of Diverticular Disease With Aminosalicylates: The Evidence.
    Barbara G; Cremon C; Barbaro MR; Bellacosa L; Stanghellini V
    J Clin Gastroenterol; 2016 Oct; 50 Suppl 1():S60-3. PubMed ID: 27622369
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Intermittent treatment with mesalazine in the prevention of diverticulitis recurrence: a randomised multicentre pilot double-blind placebo-controlled study of 24-month duration.
    Parente F; Bargiggia S; Prada A; Bortoli A; Giacosa A; Germanà B; Ferrari A; Casella G; De Pretis G; Miori G;
    Int J Colorectal Dis; 2013 Oct; 28(10):1423-31. PubMed ID: 23754545
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effectiveness of different therapeutic strategies in preventing diverticulitis recurrence.
    Tursi A; Elisei W; Giorgetti GM; Inchingolo CD; Nenna R; Picchio M; Maiorano M; Penna A; Lecca PG; Brandimarte G
    Eur Rev Med Pharmacol Sci; 2013 Feb; 17(3):342-8. PubMed ID: 23426537
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Expanding applications: the potential usage of 5-aminosalicylic acid in diverticular disease.
    Tursi A; Joseph RE; Streck P
    Dig Dis Sci; 2011 Nov; 56(11):3112-21. PubMed ID: 21567193
    [TBL] [Abstract][Full Text] [Related]  

  • 17. One year intermittent rifaximin plus fibre supplementation vs. fibre supplementation alone to prevent diverticulitis recurrence: a proof-of-concept study.
    Lanas A; Ponce J; Bignamini A; Mearin F
    Dig Liver Dis; 2013 Feb; 45(2):104-9. PubMed ID: 23092785
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Budesonide 9 mg is at least as effective as mesalamine 4.5 g in patients with mildly to moderately active Crohn's disease.
    Tromm A; Bunganič I; Tomsová E; Tulassay Z; Lukáš M; Kykal J; Bátovský M; Fixa B; Gabalec L; Safadi R; Kramm HJ; Altorjay I; Löhr H; Koutroubakis I; Bar-Meir S; Stimac D; Schäffeler E; Glasmacher C; Dilger K; Mohrbacher R; Greinwald R;
    Gastroenterology; 2011 Feb; 140(2):425-434.e1; quiz e13-4. PubMed ID: 21070781
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Review article: the current and evolving treatment of colonic diverticular disease.
    Tursi A; Papagrigoriadis S
    Aliment Pharmacol Ther; 2009 Sep; 30(6):532-46. PubMed ID: 19549266
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Diverticulosis/diverticulitis? What are conservative therapy possibilities?].
    Rinas U; Adamek HE
    Med Klin (Munich); 2006 Jan; 101(1):49-57; quiz 58-9. PubMed ID: 16418814
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 15.